Trial Profile
Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus (GHDM).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Metabolic syndrome
- Focus Therapeutic Use
- Acronyms GHDM; GHNIDDM
- 15 Nov 2008 New trial record.